Efficacy and safety of switching from Eculizumab to Ravulizumab for the maintenance of aHUS remission after kidney transplant: a preliminary experience
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Efficacy and safety of switching from Eculizumab to Ravulizumab for the maintenance of aHUS remission after kidney transplant: a preliminary experience ; day:16 ; month:7 ; year:2024 ; pages:1-3
Journal of nephrology ; (16.7.2024), 1-3
- Creator
-
Busutti, Marco
Maritati, Federica
Borelli, Greta
Bini, Claudia
Corradetti, Valeria
Cuna, Vania
Abenavoli, Chiara
Provenzano, Michele
Ravaioli, Matteo
La Manna, Gaetano
Comai, Giorgia
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s40620-024-02005-7
- URN
-
urn:nbn:de:101:1-2410090958272.122091369983
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:24 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Busutti, Marco
- Maritati, Federica
- Borelli, Greta
- Bini, Claudia
- Corradetti, Valeria
- Cuna, Vania
- Abenavoli, Chiara
- Provenzano, Michele
- Ravaioli, Matteo
- La Manna, Gaetano
- Comai, Giorgia
- SpringerLink (Online service)
Other Objects (12)
Pregnancy-triggered atypical hemolytic uremic syndrome (aHUS): a Global aHUS Registry analysis
Clinical efficacy and safety of switching from eculizumab to ravulizumab in adult patients with aHUS– real-world data
The global aHUS registry: methodology and initial patient characteristics
The global aHUS registry: methodology and initial patient characteristics
Eculizumab treatment in paediatric patients diagnosed with aHUS after haematopoietic stem cell transplantation: a HSCT-TMA case series from Japanese aHUS post-marketing surveillance
Ahus
Ahus
Charakterisierung von Patienten mit atypischem hämolytisch-urämischen Syndrom (aHUS) in Deutschland : Daten aus dem globalen aHUS-Register
Outcomes following second allogeneic stem cell transplant for disease relapse after T cell depleted transplant correlate with remission status and remission duration after the first transplant
Konsulate - Länder: Ahus
Different approaches to long-term treatment of aHUS due to MCP mutations: a multicenter analysis
Functional similarity of ABP 959 and eculizumab in simulated serum models of aHUS and NMOSD
Pregnancy-triggered atypical hemolytic uremic syndrome (aHUS): a Global aHUS Registry analysis
Clinical efficacy and safety of switching from eculizumab to ravulizumab in adult patients with aHUS– real-world data
The global aHUS registry: methodology and initial patient characteristics
The global aHUS registry: methodology and initial patient characteristics
Eculizumab treatment in paediatric patients diagnosed with aHUS after haematopoietic stem cell transplantation: a HSCT-TMA case series from Japanese aHUS post-marketing surveillance
Ahus
Ahus
Charakterisierung von Patienten mit atypischem hämolytisch-urämischen Syndrom (aHUS) in Deutschland : Daten aus dem globalen aHUS-Register
Outcomes following second allogeneic stem cell transplant for disease relapse after T cell depleted transplant correlate with remission status and remission duration after the first transplant
Konsulate - Länder: Ahus
Different approaches to long-term treatment of aHUS due to MCP mutations: a multicenter analysis
Functional similarity of ABP 959 and eculizumab in simulated serum models of aHUS and NMOSD
Pregnancy-triggered atypical hemolytic uremic syndrome (aHUS): a Global aHUS Registry analysis
Clinical efficacy and safety of switching from eculizumab to ravulizumab in adult patients with aHUS– real-world data
The global aHUS registry: methodology and initial patient characteristics
The global aHUS registry: methodology and initial patient characteristics
Eculizumab treatment in paediatric patients diagnosed with aHUS after haematopoietic stem cell transplantation: a HSCT-TMA case series from Japanese aHUS post-marketing surveillance
Ahus
Ahus
Charakterisierung von Patienten mit atypischem hämolytisch-urämischen Syndrom (aHUS) in Deutschland : Daten aus dem globalen aHUS-Register
Outcomes following second allogeneic stem cell transplant for disease relapse after T cell depleted transplant correlate with remission status and remission duration after the first transplant
Konsulate - Länder: Ahus
Different approaches to long-term treatment of aHUS due to MCP mutations: a multicenter analysis